Review Papers Claim by Claim

Visual, evidence-based critique: "Centrioles take center stage" (Marshall, 2001)

Critical appraisal — strengths

• Scope and synthesis: Marshall integrates ultrastructure, genetics (Chlamydomonas, Drosophila, C. elegans), and cell biology into a coherent 9-step duplication cycle that remains a useful conceptual scaffold Marshall 9-step cycle
• Experimental grounding: Cites genetics (asl, cnn, zyg-1, bld2) and microsurgery/ablation studies linking centriole status to cytokinesis/spindle orientation and cell-cycle progression (G1 arrest after centriole loss) Genetic & microsurgical evidence
• Research agenda setter: Calls for proteomics and in vitro reconstitution; later work (centrosome proteomics, cryo-ET, PLK4 axis) realized that agenda Marshall calls for proteomics/reconstitution

Critical appraisal — limitations & blind spots

• Resolution-limited inference: Many structural assertions are based on classical EM; the paper predates high-resolution cryo-ET and U-ExM that later resolved inner-scaffold/CID features and molecular assignments (SAS-6, CEP135, CPAP, POC proteins) Guichard et al. 2021 architecture review
• Generality vs species divergence: The review occasionally extrapolates across taxa (from Chlamydomonas/Paramecium to vertebrates) without always flagging species-specific architectures and regulatory differences later documented (e.g., deuterosome-driven multiciliogenesis, centriole elimination in oogenesis) MCC 2-in-1 cycle (2024)
• Mechanistic gaps (then & now): The review highlights cell-cycle kinases (Cdk2, ZYG-1) and candidates but could not provide molecular cascades now understood around PLK4-STIL-SAS6 or centriole-to-mother conversion factors (Cep295) which were identified after 2001 Cep295 centriole conversion 2016
• Limited discussion of disease connections mechanistically: Marshall notes centrosome/aneuploidy links to cancer but mechanistic pathways (PLK4-driven amplification, centrosome clustering in cancer cells) were immature in 2001 and expanded later Gönczy & Bornens 2009 disease review

How well the paper anticipated later advances (evidence links)

1. Proteomic parts list: Marshall predicted proteomics; subsequent centriolar proteomes and scaffold proteins (Cep295, Cep192, pericentrin/kendrin) were identified Nigg & Stearns 2007 review
2. Three-region architecture: modern cryo-ET and U-ExM split the centriole into proximal cartwheel, central inner scaffold, distal appendage regions—refining Marshall's structural discussion (but providing molecular identity) Guichard et al. 2021
3. De novo vs templated regulation: Marshall proposed suppression of de novo assembly by existing centrioles; kinetic experiments in Chlamydomonas and other systems support both templated dominance and regulated de novo assembly in specialized contexts (e.g., oocytes, multiciliated cells) Marshall on de novo vs templatedPeel et al. 2007 overexpression

Where Marshall 2001 is still useful (and where to update it)

• Useful: Conceptual 9-stage centriole cycle; links between centriole number and spindle geometry; emphasis on genetic models and the need for molecular parts lists.
• Needs updating: Add PLK4–STIL–SAS6 molecular cascade for cartwheel initiation, Cep295 and Cep192 role in daughter-to-mother conversion, the inner scaffold / CID assignments from cryo-ET, and cell-type variants (MCC deuterosome pathway) McIdas-PLK4 2026

Practical recommendations for someone using this paper today

1. Use Marshall 2001 as a historical and conceptual foundation; cross-check each mechanistic statement against modern reviews (2010–2024) for molecular detail and species variation Gönczy & Bornens 2009.
2. For structural molecular identities use cryo-ET/U-ExM focused syntheses (2021) rather than 2001 ultrastructure-only descriptions Guichard et al. 2021.
3. To design experiments: treat Marshall's staged model as a scaffold—test specific molecular hypotheses with PLK4/STIL/SAS6 perturbations, Cep295 conversion assays, and high-resolution imaging (cryo-ET, ExM) in the appropriate cell type (somatic vs multiciliated vs oocyte) DSas-6 overexpression (2007).

Counterpoints, biases, and reproducibility concerns

• Publication and selection bias: as a narrative review, it privileges positive, high-profile findings; negative or contradictory results may be underrepresented (a general issue Marshall notes indirectly).
• Cross-species extrapolation risk: Marshall uses algae, flies, worms and vertebrates; subsequent work shows important organism- and cell-type-specific differences—treat generalizations cautiously Drosophila centriole inactivation 2025.
• Reproducibility: the review summarizes many primary experiments with varying methods; replication depends on those primary methods (microsurgery, EM, genetics). For mechanistic claims, consult primary molecular studies (PLK4, Cep295) for reproducible biochemical detail Cep295 2016 mechanistic study.

Conclusions — succinct, evidence-weighted

Marshall 2001 is a rigorous, influential narrative review that set a conceptual framework (nine-step centriole cycle, templated vs de novo assembly, centriole role in centrosome/ cytokinesis/ cell-cycle control) which guided subsequent mechanistic work. The paper's main weaknesses are intrinsic to its time: limited molecular resolution and incomplete appreciation of cell-type specific centriole biogenesis routes now revealed by proteomics, PLK4-centric molecular genetics, cryo-ET, and MCC/deuterosome studies. Use Marshall as historical foundation plus modern structural/molecular reviews for up-to-date mechanistic detail Marshall 2001 summary.